Medtronic Faces Intensified Scrutiny Amid 23 Recalls in One Year as It Files IPO Prospectus
Medtronic
Medical Device Manufacturer
Click above "Medical Device Business Review"--Upper Right Corner"…"--Set asStar Mark
Source:Medical Device Innovation Network
According to statistics from relevant media, based on the medical device recall information disclosed by the National Medical Products Administration in the past year (July 1, 2023 – June 30, 2024), well-known medical device companiesMedtronicMost of the information pertains to voluntary recalls, with a total of 23 entries, which is higher thanOlympus (13 items), Philips (6 items), Siemens (3 items), etc.Peer, involving 36 batches of products such as mobile O-arm X-ray machines.
As a globally renowned medical device company, Medtronic's innovative technologies span four major medical fields: cardiovascular, surgical and critical care, neuroscience, and diabetes, covering more than 70 major disease areas. Its business extends to over 150 countries and regions worldwide, with a workforce of more than 90,000 employees.
According to Medtronic's official website, every second, two patients worldwide benefit from its medical technologies or therapies. The company’s fiscal year 2024 report (covering the period from April 29, 2023, to April 26, 2024) shows that the total revenue for the reporting period was $32.364 billion, with revenue from emerging markets, including Greater China, reaching $5.823 billion, representing a year-on-year increase of 6.9%.Cardiac and Vascular business becomes the only business portfolio with revenue exceeding 10 billion US dollars, reaching 11.831 billion US dollars.
Precisely because of Medtronic's prominent position, its 23 recalls have drawn particular attention, especially on September 15, 2023, when four out of six recall announcements published on the official website of China's National Medical Products Administration were from Medtronic.
These recalls are mainly due to incompatibility issues between the updated A710 CP application (v2.0.136) and the existing A901 Communication Manager application (v1.0.1169), which prevent the A710 CP application from effectively communicating with the Implantable Neurostimulator (INS) and Wireless External Neurostimulator (WENS). As a result, Medtronic initiated a Class II recall for related products, including the Spinal Cord Stimulator Clinician Programmer System, Patient Programmer, and Neuromodulation Device Programmer.
Regarding the specific reasons for the recall of the products and how to ensure the details of product quality management, Medtronic did not provide a detailed explanation in its response to the media, but merely emphasized"Proactive recall is an important part of our quality management system."This indicates that they value product quality and safeguard patients' safety and the company's reputation through a recall mechanism.
In the past year, Medtronic has had a relatively high number of recalls, and other companies with a large number of recalls includeOlympus, StrykerAnd other companies:
(Cartography: Medical Device Innovation Network)
Currently, the recall of medical device products has become one of the important risk control measures after market entry. According to the provisions of the "Measures for the Administration of Medical Device Recalls," recalls are divided into three levels based on the severity of the medical device defect: Level 1 Recall (the use of the medical device may or has already caused serious health hazards); Level 2 Recall (the use of the medical device may or has already caused temporary or reversible health hazards); Level 3 Recall (the use of the medical device poses a smaller possibility of harm but still requires a recall).
Among the 23 recalls conducted by Medtronic in the past year, two involved China and were both classified as Class I recalls (the use of the medical device may or has already caused serious health hazards).The sales volume of these products in China was 12,569, of which the sales volume of external drainage devices was 12,367.
March 26, 2024
Product: External Drainage Device
Reason for Recall: The patient connection tubing of the external drainage system may disconnect at the three-way valve or Luer connector, potentially causing harm to patients including infection, cerebrospinal fluid leakage, excessive cerebrospinal fluid drainage, and ventricular abnormalities. Severe cases could even lead to nerve damage or death.
Recall Quantity: 13,099
Number of products sold in China: 12,367
May 22, 2024
Products: Neurosurgical Navigation System, Spine Surgical Navigation System, ENT Surgical Navigation System
Reason for Recall: Due to a software anomaly in certain versions, there may be an incorrect depth-limit prompt for the biopsy needle during surgery, which could potentially lead to permanent nerve damage in patients.
Recall Quantity: 266
Number of design products sold in China: 202
Medtronic, as a globally renowned medical device company, its products cover multiple highly complex medical fields such as cardiovascular, surgical and critical care, neuroscience, and diabetes. The complexity of technological innovation increases the risk of potential defects, especially during the rapid iteration of new products and technologies.Moreover, with its operations spanning over 150 countries and regions worldwide, facing diverse regulatory requirements and standards, even a minor error in any环节 could trigger a product recall.
Even though Medtronic has a rigorous quality management system, challenges in large-scale production and supply chain management still exist, leading to multiple voluntary recalls. These recalls not only reflect the company's swift response to product safety but also highlight the necessity of strengthening quality control and risk management in design and production.
Every recall represents a profound reflection on the safety standards of medical devices, offering valuable opportunities for future device improvements. It serves as both a test of corporate responsibility and an evaluation of the effectiveness of the regulatory system. Ensuring the safety and efficacy of medical devices requires the joint efforts of companies, regulatory agencies, and the entire industry.
In response to the recall incident, the entire industry should be highly vigilant and committed to improving the safety standards of medical devices to ensure that every patient receives the safest and most effective treatment. Transparency, rapid response, and effective solutions are crucial for rebuilding public trust in the safety of medical devices.
As emphasized by the U.S. Food and Drug Administration (FDA), recalls are a necessary part of the medical device lifecycle management, aimed at protecting public health. We look forward to seeing more positive initiatives to jointly promote the continuous progress and improvement of the healthcare industry.
This article is reprinted, all views belong to the original author.Platform (Medical Device Innovation Network), Medical DeviceThe Medical Business Review remains neutral on all viewpoints in the article and only shares them for communication purposes.
*Advertisement
New Medical Device Products
Cutting-edge Technology in the Industry
Global Hot News
Medical Device Business Review Exchange Group is sharing enthusiastically......
▼More Book Recommendations▼
If you find the content helpful, welcomeStar Mark、Like、Forward！
Your support is our greatest motivation
